Home » Topics » BioWorld Science

BioWorld Science
RSS

New catalytic system allows selective cancer cell targeting

July 11, 2019

Chengdu Huajian Future Technology patents IDO-1 inhibitors

July 11, 2019

New PD-1/PD-L1 interaction inhibitors described by Yangtze River, Shanghai Haiyan

July 11, 2019

Chiesi discovers Rho kinase inhibitors

July 11, 2019

Guangdong Newopp Biopharmaceuticals presents new arginase inhibitors

July 11, 2019

Researchers develop CRISPR/Cas9 hemophilia A murine model

July 11, 2019

First patient dosed in phase II study of KD-025 in cutaneous systemic sclerosis

July 11, 2019

FDA clears Syndax's IND for phase I/II trial of SNDX-5613 for relapsed/refractory acute leukemias

July 11, 2019

Preclinical evaluation of enzymatically cleavable lipoglycopeptides for pulmonary MRSA

July 11, 2019

New vaccine protects nonhuman primates against equine encephalitis viruses

July 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...